Denali Therapeutics News

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ho Carole

Nov 28 05:48

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schuth Alexander O.

Nov 27 06:23

Denali Therapeutics | 8-K: Current report

Nov 19 05:06

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schenkein David P

Nov 14 05:24

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SATO VICKI L

Nov 13 05:49

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schuth Alexander O.

Nov 13 05:49

Denali Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital Research Global Investors(5.5%)

Nov 13 01:58

Denali Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.084%),Abigail P. Johnson(7.084%)

Nov 12 23:00

Denali Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 12 22:29

Denali Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.6%)

Nov 9 06:39

Denali Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(7.49%),Wellington Group Holdings LLP(7.49%), etc.

Nov 8 23:55

Denali Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biogen Inc.(4.97%),Biogen MA Inc.(4.97%)

Nov 8 05:58

Denali Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 8 05:46

Denali Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 05:22

Denali Therapeutics | 8-K: Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7 05:21

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SATO VICKI L

Nov 6 05:28

Denali Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watts Ryan J.

Oct 23 04:34

Denali Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.6%)

Oct 22 04:19

Denali Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 19 04:24

Denali Therapeutics | 8-K: Current report

Oct 11 04:05